GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » KPC Pharmaceuticals Inc (SHSE:600422) » Definitions » PS Ratio

KPC Pharmaceuticals (SHSE:600422) PS Ratio : 1.51 (As of Apr. 26, 2025)


View and export this data going back to 2000. Start your Free Trial

What is KPC Pharmaceuticals PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, KPC Pharmaceuticals's share price is ¥16.94. KPC Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ¥11.19. Hence, KPC Pharmaceuticals's PS Ratio for today is 1.51.

The historical rank and industry rank for KPC Pharmaceuticals's PS Ratio or its related term are showing as below:

SHSE:600422' s PS Ratio Range Over the Past 10 Years
Min: 0.67   Med: 1.33   Max: 4.69
Current: 1.53

During the past 13 years, KPC Pharmaceuticals's highest PS Ratio was 4.69. The lowest was 0.67. And the median was 1.33.

SHSE:600422's PS Ratio is ranked better than
61.71% of 961 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs SHSE:600422: 1.53

KPC Pharmaceuticals's Revenue per Sharefor the three months ended in Dec. 2024 was ¥3.96. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ¥11.19.

Good Sign:

KPC Pharmaceuticals Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of KPC Pharmaceuticals was 0.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.90% per year.

During the past 13 years, KPC Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 38.00% per year. The lowest was 0.80% per year. And the median was 12.10% per year.

Back to Basics: PS Ratio


KPC Pharmaceuticals PS Ratio Historical Data

The historical data trend for KPC Pharmaceuticals's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KPC Pharmaceuticals PS Ratio Chart

KPC Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 1.01 1.28 1.88 1.42

KPC Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.88 1.94 1.65 1.46 1.42

Competitive Comparison of KPC Pharmaceuticals's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, KPC Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


KPC Pharmaceuticals's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, KPC Pharmaceuticals's PS Ratio distribution charts can be found below:

* The bar in red indicates where KPC Pharmaceuticals's PS Ratio falls into.


;
;

KPC Pharmaceuticals PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

KPC Pharmaceuticals's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=16.94/11.185
=1.51

KPC Pharmaceuticals's Share Price of today is ¥16.94.
KPC Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥11.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


KPC Pharmaceuticals  (SHSE:600422) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


KPC Pharmaceuticals PS Ratio Related Terms

Thank you for viewing the detailed overview of KPC Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


KPC Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
Executives
Qu Xiao Ru senior management
Xie Bo senior management
Meng Li senior management
Zhong Xiang Gang senior management
Wu Sheng Long senior management
Liu Jun Feng senior management
Wang Lei senior management
Zhang Meng Xun senior management
Hu Zhen Bo senior management
Sun Lei senior management
Xu Chao Neng senior management
Wang Jun senior management
Zhao Jian senior management
He Qin Director
Dai Xiao Chang senior management

KPC Pharmaceuticals Headlines

No Headlines